AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12219064 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG 3350 at 0.5 g/kg per day
Number of subjects: 40
Study 10075218 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 7867871 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg 5‐isosorbide mononitrate once daily
Number of subjects: 31
Study 7867871 — intervention group
Group type: COMPARATOR
Intervention: 20 mg 5‐isosorbide mononitrate twice daily
Number of subjects: 31
Study 2758298 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy subjects tapping response with preferred fixed time interval (1, 2, 3, or 4 s)
Number of subjects: 6
Study 2758298 — intervention group
Group type: COMPARATOR
Intervention: Patients tapping with the hand related to the involved hemisphere
Number of subjects: 6
Study 2758298 — intervention group
Group type: COMPARATOR
Intervention: Patients tapping with either hand
Number of subjects: 6
Study 1026547 — intervention group
Group type: EXPERIMENTAL
Intervention: 0-1% halcinonide cream (with neomycin and nystatin)
Number of subjects: 50
Study 1026547 — intervention group
Group type: COMPARATOR
Intervention: 1% hydrocortisone cream
Number of subjects: 50
Study 29672368 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Number of subjects: 128
Study 29672368 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 128
Study 29672368 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine (major surgery subgroup)
Number of subjects: 128
Study 29672368 — intervention group
Group type: COMPARATOR
Intervention: Placebo (major surgery subgroup)
Number of subjects: 128
Study 26202101 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-segment posterior fixation (SSPF)
Number of subjects: 24
Study 26202101 — intervention group
Group type: COMPARATOR
Intervention: Long-segment posterior fixation (LLPF)
Number of subjects: 24
Study 23823582 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration exercise training (WBVET)
Number of subjects: 28
Study 23823582 — intervention group
Group type: COMPARATOR
Intervention: No-exercise control
Number of subjects: 28
Study 22059933 — intervention group
Group type: EXPERIMENTAL
Intervention: Coban 2 system applied two times per week
Number of subjects: 82
Study 22059933 — intervention group
Group type: EXPERIMENTAL
Intervention: Coban 2 system applied three times per week
Number of subjects: 82
Study 22059933 — intervention group
Group type: EXPERIMENTAL
Intervention: Coban 2 system applied five times per week
Number of subjects: 82
Study 22059933 — intervention group
Group type: COMPARATOR
Intervention: Short-stretch bandaging five times per week
Number of subjects: 82
Study 20223497 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous taurolidine in crystalloid cardioplegia
Number of subjects: 60
Study 20223497 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion of normal saline in crystalloid cardioplegia
Number of subjects: 60
Study 20223497 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous taurolidine in blood cardioplegia
Number of subjects: 60
Study 20223497 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion of normal saline in blood cardioplegia
Number of subjects: 60
Study 17905272 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 120
Study 17905272 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 120
Study 17905272 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane (in patients with concomitant coronary artery disease)
Number of subjects: 120
Study 17905272 — intervention group
Group type: COMPARATOR
Intervention: Propofol (in patients with concomitant coronary artery disease)
Number of subjects: 120
Study 16267446 — intervention group
Group type: EXPERIMENTAL
Intervention: External percutaneous approach
Number of subjects: 50
Study 16267446 — intervention group
Group type: COMPARATOR
Intervention: Transnasal internal lateral osteotomy (control)
Number of subjects: 50
Study 12153370 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart failure randomized controlled trials (RCTs)
Number of subjects: 59
Study 10507423 — intervention group
Group type: EXPERIMENTAL
Intervention: Early parenteral nutrition (PN) for 5 days, starting 24 to 48 hours after surgery
Number of subjects: 63
Study 10507423 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (fluids)
Number of subjects: 63
Study 8942456 — intervention group
Group type: EXPERIMENTAL
Intervention: New rating system for personality disorder severity
Number of subjects: 163
Study 8942456 — intervention group
Group type: COMPARATOR
Intervention: Old rating system for personality disorder severity
Number of subjects: 163
Study 8942456 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffuse personality disorder
Number of subjects: 163
Study 1748135 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine 10 mg ER o.d.
Number of subjects: 28
Study 1748135 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide 25 mg o.d.
Number of subjects: 28
Study 6817761 — intervention group
Group type: EXPERIMENTAL
Intervention: mesna (sodium 2-mercaptoethane sulfonate)
Number of subjects: 20
Study 6817761 — intervention group
Group type: COMPARATOR
Intervention: standard prophylactic measures
Number of subjects: 20
Study 30888982 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle strengthening and balancing exercises for 10 weeks
Number of subjects: 45
Study 30888982 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 45
Study 31014546 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group 1 (updated version of a guideline-based multicomponent intervention)
Number of subjects: 12245
Study 31014546 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group 2 (concise version of the original program)
Number of subjects: 12245
Study 31014546 — intervention group
Group type: COMPARATOR
Intervention: Control group (optimized usual care)
Number of subjects: 12245
Study 31014546 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary outcomes (falls, fall-related fractures, quality of life)
Number of subjects: 12245
Study 27670395 — intervention group
Group type: EXPERIMENTAL
Intervention: High cut-off serum
Number of subjects: 0
Study 27670395 — intervention group
Group type: EXPERIMENTAL
Intervention: High cut-off dialysates
Number of subjects: 0
Study 27670395 — intervention group
Group type: COMPARATOR
Intervention: High flux membrane treatment
Number of subjects: 0
Study 26143019 — intervention group
Group type: EXPERIMENTAL
Intervention: PE HCl 10 mg
Number of subjects: 539
Study 26143019 — intervention group
Group type: EXPERIMENTAL
Intervention: PE HCl 20 mg
Number of subjects: 539
Study 26143019 — intervention group
Group type: EXPERIMENTAL
Intervention: PE HCl 30 mg
Number of subjects: 539
Study 26143019 — intervention group
Group type: EXPERIMENTAL
Intervention: PE HCl 40 mg
Number of subjects: 539
Study 26143019 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 539
Study 25347696 — intervention group
Group type: EXPERIMENTAL
Intervention: Agave nectar
Number of subjects: 0
Study 25347696 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 0
Study 25347696 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study 22227852 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise (five sets of six maximal eccentric actions of the elbow flexors)
Number of subjects: 17
Study 22227852 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise
Number of subjects: 17
Study 20929592 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocotrienol rich fraction (TRF) plus tamoxifen
Number of subjects: 240
Study 20929592 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus tamoxifen
Number of subjects: 240
Study 17586188 — intervention group
Group type: EXPERIMENTAL
Intervention: Palivizumab
Number of subjects: 421
Study 17586188 — intervention group
Group type: COMPARATOR
Intervention: Control (no palivizumab)
Number of subjects: 421
Study 17586188 — intervention group
Group type: COMPARATOR
Intervention: Control (not hospitalized for RSV)
Number of subjects: 421
Study 15906759 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabexate mesilate (GM) at a dose of 600 mg/24 hr
Number of subjects: 16
Study 15906759 — intervention group
Group type: COMPARATOR
Intervention: Physiological solution (control)
Number of subjects: 16
Study 15906759 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabexate mesilate (GM)
Number of subjects: 16
Study 15906759 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide (administered to 7 patients post-study)
Number of subjects: 16
Study 12388617 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopaminergic therapy (dopamine-replete state)
Number of subjects: 2
Study 12388617 — intervention group
Group type: COMPARATOR
Intervention: Hypodopaminergic state (i.e., > or =12 hr after last dose of dopaminergic treatment)
Number of subjects: 2
Study 12388617 — intervention group
Group type: COMPARATOR
Intervention: Normal controls (NCs)
Number of subjects: 2
Study 10445794 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (160 mg/day)
Number of subjects: 206
Study 10445794 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206
Study 10445794 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 206
Study 8775804 — intervention group
Group type: EXPERIMENTAL
Intervention: Saquinavir monotherapy
Number of subjects: 0
Study 8775804 — intervention group
Group type: EXPERIMENTAL
Intervention: Saquinavir combination therapy with zidovudine
Number of subjects: 0
Study 8775804 — intervention group
Group type: EXPERIMENTAL
Intervention: Saquinavir combination therapy with zidovudine and zalcitabine
Number of subjects: 0
Study 8775804 — intervention group
Group type: COMPARATOR
Intervention: Saquinavir at higher doses (2-4 times higher)
Number of subjects: 0
Study 8775804 — intervention group
Group type: EXPERIMENTAL
Intervention: Saquinavir
Number of subjects: 0
Study 2155739 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold compress at 0 degrees C applied bilaterally for 40 seconds
Number of subjects: 16
Study 2155739 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold compress at 120 seconds
Number of subjects: 16
Study 6982843 — intervention group
Group type: EXPERIMENTAL
Intervention: Carprofen
Number of subjects: 10
Study 6982843 — intervention group
Group type: COMPARATOR
Intervention: Acetylsalicylic acid
Number of subjects: 10
Study 6982843 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin
Number of subjects: 10
Study 6982843 — intervention group
Group type: COMPARATOR
Intervention: Piroxicam
Number of subjects: 10
Study 6982843 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac
Number of subjects: 10
Study 31133067 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition-sensitive agricultural extension intervention (women's groups viewing videos on nutrition-sensitive agriculture practices)
Number of subjects: 0
Study 31133067 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition-specific behaviour-change intervention (videos on nutrition)
Number of subjects: 0
Study 31133067 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory learning and action approach
Number of subjects: 0
Study 31133067 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-consequence analysis
Number of subjects: 0
Study 31133067 — intervention group
Group type: EXPERIMENTAL
Intervention: Equity impact analysis
Number of subjects: 0
Study 27868327 — intervention group
Group type: EXPERIMENTAL
Intervention: Doctor-patient communication with a focus on discussing medication themes and lifestyle treatment.
Number of subjects: 159
Study 27868327 — intervention group
Group type: EXPERIMENTAL
Intervention: Active patient engagement and explicit conversations about medications.
Number of subjects: 159
Study 26319158 — intervention group
Group type: EXPERIMENTAL
Intervention: Reuptake inhibitor antidepressant medication (MED)
Number of subjects: 69
Study 26319158 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 69
Study 24254885 — intervention group
Group type: EXPERIMENTAL
Intervention: EDTA chelation
Number of subjects: 633
Study 17110396 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (CC)
Number of subjects: 138
Study 17110396 — intervention group
Group type: COMPARATOR
Intervention: recombinant FSH (rFSH)
Number of subjects: 138
Study 17110396 — intervention group
Group type: EXPERIMENTAL
Intervention: Both CC and rFSH
Number of subjects: 138
Study 15491380 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine + Dexamethasone (group 1, n=23)
Number of subjects: 69
Study 15491380 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol + Dexamethasone (group 2, n=23)
Number of subjects: 69
Study 15491380 — intervention group
Group type: COMPARATOR
Intervention: Epinephrine + Placebo (group 3, n=11)
Number of subjects: 69
Study 15491380 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol + Placebo (group 4, n=12)
Number of subjects: 69
Study 11093503 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracoscopy
Number of subjects: 42
Study 11093503 — intervention group
Group type: COMPARATOR
Intervention: Thoracotomy
Number of subjects: 42
Study 9484914 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 0
Study 9484914 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy given prior to or simultaneously with definite radiotherapy
Number of subjects: 0
Study 9484914 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 0
Study 9484914 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose isotretinoin
Number of subjects: 0
Study 8455920 — intervention group
Group type: EXPERIMENTAL
Intervention: Critical Path Method (CPM) rehabilitation team
Number of subjects: 121
Study 8455920 — intervention group
Group type: COMPARATOR
Intervention: Usual care teams
Number of subjects: 121
Study 3510016 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma Command (educational intervention by computer)
Number of subjects: 65
Study 3510016 — intervention group
Group type: COMPARATOR
Intervention: Routine computer games (control)
Number of subjects: 65
Study 31982416 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted motivational interviewing
Number of subjects: 232
Study 31982416 — intervention group
Group type: COMPARATOR
Intervention: Educational video with counseling
Number of subjects: 232
Study 31982416 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 232
Study 30521075 — intervention group
Group type: EXPERIMENTAL
Intervention: SHARE (Spouses coping with the Head And neck Radiation Experience)
Number of subjects: 60
Study 30521075 — intervention group
Group type: COMPARATOR
Intervention: Usual Medical Care (UMC)
Number of subjects: 60
Study 28627732 — intervention group
Group type: EXPERIMENTAL
Intervention: Loperamide 12 mg/day
Number of subjects: 12
Study 28627732 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 26192328 — intervention group
Group type: EXPERIMENTAL
Intervention: Danshen (water-extract of Salvia Miltiorrhiza root)
Number of subjects: 20
Study 26192328 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 23469870 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser treatment (Group A, n=14)
Number of subjects: 28
Study 23469870 — intervention group
Group type: COMPARATOR
Intervention: Conventional instruments (Group B, n=14)
Number of subjects: 28
Study 21247302 — intervention group
Group type: EXPERIMENTAL
Intervention: Drainage group (YD)
Number of subjects: 116
Study 21247302 — intervention group
Group type: COMPARATOR
Intervention: Nondrainage group (ND)
Number of subjects: 116
Study 18804285 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT) for depression
Number of subjects: 156
Study 17154670 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 0
Study 14767273 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoreductive nephrectomy plus interferon alpha‐2b
Number of subjects: 331
Study 14767273 — intervention group
Group type: COMPARATOR
Intervention: Interferon alpha‐2b alone
Number of subjects: 331
Study 11237928 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorogenic acid (2 g daily)
Number of subjects: 20
Study 11237928 — intervention group
Group type: EXPERIMENTAL
Intervention: Black tea (4 g daily)
Number of subjects: 20
Study 11237928 — intervention group
Group type: EXPERIMENTAL
Intervention: Quercetin‐3‐rutinoside (440 mg daily)
Number of subjects: 20
Study 11237928 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 9251874 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan (6 mg sc)
Number of subjects: 424
Study 8280556 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoximone (loading dose of 0.5 mg kg‐1 followed by an infusion of 5 micrograms kg‐1 min‐1)
Number of subjects: 20
Study 8280556 — intervention group
Group type: EXPERIMENTAL
Intervention: Piroximone (loading dose of 0.5 mg kg‐1 followed by an infusion of 5 micrograms kg‐1 min‐1)
Number of subjects: 20
Study 3502447 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic cerebellar stimulation (CCS)
Number of subjects: 30
Study 30853117 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life
Number of subjects: 263
Study 30853117 — intervention group
Group type: EXPERIMENTAL
Intervention: Hopelessness
Number of subjects: 263
Study 30853117 — intervention group
Group type: EXPERIMENTAL
Intervention: Central obesity
Number of subjects: 263
Study 30853117 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective recovery
Number of subjects: 263
Study 28975710 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole augmentation
Number of subjects: 181
Study 28975710 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 181
Study 26974559 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral (CB) group
Number of subjects: 56
Study 26974559 — intervention group
Group type: EXPERIMENTAL
Intervention: Complementary and Alternative Medicine - Cognitive Behavioral (CAM-CB) group
Number of subjects: 56
Study 26974559 — intervention group
Group type: EXPERIMENTAL
Intervention: CAM-CB group
Number of subjects: 56
Study 26974559 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 56
Study 24917119 — intervention group
Group type: EXPERIMENTAL
Intervention: Grintuss® pediatric syrup
Number of subjects: 100
Study 24917119 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 22401329 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly automated telephone self-management (ATSM) support with nurse care management
Number of subjects: 330
Study 22401329 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly group medical visits (GMVs)
Number of subjects: 330
Study 22401329 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 330
Study 20551827 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation (PR) commenced in winter
Number of subjects: 95
Study 20551827 — intervention group
Group type: COMPARATOR
Intervention: Pulmonary rehabilitation (PR) commenced in spring, summer, or autumn
Number of subjects: 95
Study 20551827 — intervention group
Group type: COMPARATOR
Intervention: Incremental Shuttle Walking Test (ISWT) scores
Number of subjects: 95
Study 20551827 — intervention group
Group type: COMPARATOR
Intervention: Chronic Respiratory Disease Questionnaire‐Self Reported
Number of subjects: 95
Study 18657652 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil-sustained release (SR) strategy
Number of subjects: 7218
Study 18657652 — intervention group
Group type: COMPARATOR
Intervention: Atenolol-based strategy
Number of subjects: 7218
Study 16317218 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 1 mg IV plus dexamethasone 20 mg (group A)
Number of subjects: 39
Study 16317218 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 3 mg IV plus dexamethasone 20 mg (group B)
Number of subjects: 39
Study 12821974 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (40 mg/day)
Number of subjects: 25
Study 12821974 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 11322152 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional neuromuscular stimulation (FNS)
Number of subjects: 5
Study 11322152 — intervention group
Group type: COMPARATOR
Intervention: No FNS (control)
Number of subjects: 5
Study 8864768 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenytoin (PHT)
Number of subjects: 32
Study 8864768 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ)
Number of subjects: 32
Study 8864768 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbital (PB)
Number of subjects: 32
Study 8864768 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of PHT and PB
Number of subjects: 32
Study 8864768 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of CBZ and PB
Number of subjects: 32
Study 8864768 — intervention group
Group type: COMPARATOR
Intervention: Drug-free (DF)
Number of subjects: 32
Study 8864768 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal healthy females (NS)
Number of subjects: 32
Study 10121680 — intervention group
Group type: EXPERIMENTAL
Intervention: Videotapes
Number of subjects: 27
Study 10121680 — intervention group
Group type: COMPARATOR
Intervention: Written summaries
Number of subjects: 27
Study 10121680 — intervention group
Group type: EXPERIMENTAL
Intervention: Rating scale of videotapes
Number of subjects: 27
Study 6383763 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg dipyridamole intravenously
Number of subjects: 30
Study 6383763 — intervention group
Group type: COMPARATOR
Intervention: Placebo intravenously
Number of subjects: 30
Study 30414228 — intervention group
Group type: EXPERIMENTAL
Intervention: High obesity risk group (children with overweight/obese parents)
Number of subjects: 145
Study 30414228 — intervention group
Group type: COMPARATOR
Intervention: Low obesity risk group (children with normal-weight parents)
Number of subjects: 145
Study 30113506 — intervention group
Group type: EXPERIMENTAL
Intervention: Parecoxib
Number of subjects: 0
Study 30113506 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 26826459 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal massage plus lifestyle advice
Number of subjects: 32
Study 26826459 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle advice
Number of subjects: 32